Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Access to Advanced Sequencing Services

18 December 2024 | Wednesday | News


Eurofins to leverage Complete Genomics' DNBSEQ-T7RS™ platform for cutting-edge whole genome and single-cell sequencing, enhancing flexibility and efficiency for diverse research projects.
Image Source : Public Domain

Image Source : Public Domain

Complete Genomics, a San Jose, California based genomics tools manufacturer,  announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program. 

 

Complete Genomics' Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms.

As part of the partnership, Eurofins Clinical Enterprise will use the DNBSEQ-T7RS™* ("T7"), Complete Genomics' flagship sequencer, to perform whole genome sequencing, low-pass whole genome sequencing (lpWGS), spatial-resolved transcriptomics, and single-cell sequencing.

The Eurofins Clinical Enterprise team expressed their enthusiasm about utilizing the T7 to enhance the company's flexibility in handling a wide range of research project sizes, while maintaining competitive pricing and quick turnaround times.

"This partnership is another way that Complete Genomics and its partners are expanding what is possible while also lowering costs and turnaround time for our customers," said Rob Tarbox, VP of Product and Marketing at Complete Genomics.

 Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program. 

 

Complete Genomics' Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms.

As part of the partnership, Eurofins Clinical Enterprise will use the DNBSEQ-T7RS™* ("T7"), Complete Genomics' flagship sequencer, to perform whole genome sequencing, low-pass whole genome sequencing (lpWGS), spatial-resolved transcriptomics, and single-cell sequencing.

The Eurofins Clinical Enterprise team expressed their enthusiasm about utilizing the T7 to enhance the company's flexibility in handling a wide range of research project sizes, while maintaining competitive pricing and quick turnaround times.

"This partnership is another way that Complete Genomics and its partners are expanding what is possible while also lowering costs and turnaround time for our customers," said Rob Tarbox, VP of Product and Marketing at Complete Genomics.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close